Molecular Partners AG (MOLN)
4.204
-0.32
(-6.99%)
USD |
NASDAQ |
Dec 08, 16:00
4.15
-0.05
(-1.28%)
After-Hours: 20:00
Molecular Partners Total Liabilities (Quarterly): 20.89M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| BeOne Medicines Ltd. | 3.474B |
| AC Immune SA | 137.20M |
| CRISPR Therapeutics AG | 329.33M |
| Addex Therapeutics Ltd. | 1.725M |
| NewCelX Ltd. | -- |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 140.95M |
| Shareholders Equity (Quarterly) | 120.06M |
| Debt to Equity Ratio | 0.016 |
| Current Ratio | 9.280 |
| Net Debt Paydown Yield | 0.21% |